Industry Research Reports and Market Analysis at MindBranch.com
  

Veterinary Drug Residues & MRLs

Product Type: Market Research Report
Published by: Informa Healthcare
Published: November 2006
Product Code: R3535-42
Description
This essential management report offers a comprehensive, global overview of residue incidence by species and market. It details major causes, detection techniques and technology, and control and prevention methods.

Customers increasingly require objective information to ensure that what they put on their plates is safe. This phenomenon has fuelled the need for quality assurance upon which international food trade is dependent.

How do regulatory bodies around the world control and monitor veterinary drug residues?
  • Identify the major causes of residues.
  • Analyse the laws in place worldwide to ensure that residues are kept in check.
  • Become an expert in detection and testing techniques

Table of Contents
CHAPTER 1 MAJOR CAUSES
1.1 Introduction
1.2 Withdrawal periods
1.3 Hygiene
1.4 Misuse
1.5 Veterinarian
1.6 Risky residues
1.6.1 Hormonal growth promoters
1.6.2 Beta-agonists
1.6.3 Bovine somatotrophin
1.6.4 Penicillins
1.6.5 Cephalosporins
1.7 Selected macrolide antibiotics
1.7.1 Spiramycin
1.7.2 Tilmicosin
1.8 Aminoglycosides
1.8.1 Adverse effects
1.9 Fluoroquinolones
1.10 Sulfadimidine (sulfamethazine)
1.11 Nitrofurans and nitroimidazoles
1.12 Chloramphenicol
1.13 Ivermectin
1.14 Tranquilisers
1.14.1 Xylazine
1.14.2 Azaperone
1.15 Carazolol
CHAPTER 2 DETECTION AND TECHNOLOGY
2.1 Introduction
2.2 Ante- and post-mortem inspection
2.3 Screening methods
2.3.1 Rapid tests
2.3.2 Microbiological inhibition tests
2.3.3 Electrophoretic systems
2.3.4 Investigating further with ELISA and RIA
2.3.5 Receptor tests
2.3.6 Confirming results
2.3.7 Chromatography and spectrometry
2.3.8 Validation
2.3.9 Identification points
2.3.10 Analytical methods in the EU
2.4 Emerging technologies
2.4.1 Introduction
2.4.2 Variations on a theme
2.4.2.1 Old with the new
2.4.3 Biosensors
2.4.3.1 Surface plasmon resonance
2.4.3.2 Electrochemical biosensors
2.4.3.3 BioCop
CHAPTER 3 CONTROLS AND PREVENTION
3.1 Introduction
3.2 Registration and distribution
3.3 Veterinarian responsibilities
3.4 Farmer/producer responsibilities
3.4.1 Hygiene
3.4.2 Feed
3.4.3 Monitoring
3.4.4 Record keeping
3.5 Scrutiny
CHAPTER 4 INTERNATIONAL FOOD SAFETY AND THE CODEX ALIMENTARIUS
4.1 Introduction
4.2 Setting standards
4.3 Establishing ADIs
4.3.1 Veterinary hypothetical diet
4.4 Disadvantages
CHAPTER 5 THE EUROPEAN UNION
5.1 Legislation and Regulation
5.2 Setting MRLs
5.3 National monitoring
5.3.1 Sampling
5.3.2 Infringements
5.3.3 Residue categories
5.4 Third countries
5.4.1 Monitoring
5.4.2 Inspections
5.5 Residue incidence rates
5.5.1 Latest results
5.5.2 Non-compliant results
5.5.2.1 Hormones
5.5.2.2 Corticosteroids
5.5.2.3 Beta-agonists
5.5.2.4 Prohibited substances
5.5.2.5 Antibacterials
5.5.2.6 Anthelmintics
5.6 Incidence rate tables
5.6.1 Country codes
5.6.2 Bovines: non-compliant results
5.6.3 Pigs: non-compliant results
5.6.4 Poultry: non-compliant results
5.6.5 Sheep and goats: non-compliant results
CHAPTER 6 UNITED KINGDOM
6.1 Legislation and Regulation
6.2 Statutory surveillance
6.3 Non-statutory surveillance
6.4 Surveillance results 2005
6.4.1 Statutory results
6.4.1.1 Emamectin and malachite green in fish
6.4.1.2 Coccidiostats
6.4.1.3 Phenylbutazone in cattle and horse
6.4.1.4 Nitrofuran and Nortestosterone
6.4.2 Non-statutory results
6.4.2.1 Farmed fish and crustaceans
6.4.2.2 Retailer results
CHAPTER 7 IRELAND
7.1 Legislation and Regulation
7.2 Results 2005
7.2.1 Banned substances
7.2.2 Antibiotics
7.2.3 Anticoccidials
7.2.4 Aquaculture
7.2.5 Follow-up actions
CHAPTER 8 GERMANY
8.1 Legislation and Regulation
8.2 Non-compliant results
8.3 Results 2004
8.4 Results by substance group
8.4.1 Anabolic and unauthorised substances
8.4.2 Antibacterials
CHAPTER 9 SWITZERLAND
9.1 Legislation and regulation
9.1.1 Testing
9.1.1.1 Sample collection
9.2 Results
9.3 Infringement
CHAPTER 10 AUSTRIA
10.1 Legislation and regulation
10.2 Results 2005
CHAPTER 11 AUSTRALIA
11.1 Legislation and Regulation
11.2 Sampling
11.3 Tracing back
11.4 Results
11.4.1 Anthelmintics
11.4.2 Antibacterials
11.4.3 Hormones
11.4.4 Steroids
11.5 Incidence rates
CHAPTER 12 NEW ZEALAND
12.1 Legislation and regulation
12.1.1 Risk management
12.2 Results
CHAPTER 13 JAPAN
13.1 Legislation and regulation
13.1.1 Establishing MRLs
13.1.2 Imports
13.2 Incidence rates
13.2.1 Imported food results 2003-4
13.2.2 Imported food results 2004-5
13.2.3 Latest imported food data
13.2.4 Domestic food results 2003-4
13.2.5 Domestic food results 2004-5
CHAPTER 14 CHINA
14.1 Legislation and regulation
14.1.1 Non-compliant results
14.2 MRLs
14.3 EU relations
14.3.1 Chinese exports to EU
14.3.2 On-site inspections
14.3.2.1 Background
14.3.2.2 NRMP 2006
CHAPTER 15 HONG KONG
15.1 Legislation and Regulation
15.1.1 Inspections
15.2 Non-compliance consequences
15.3 Results
CHAPTER 16 THAILAND
16.1 Legislation and Regulation
16.2 Setting MRLs
16.3 Results
CHAPTER 17 INDIA
17.1 Legislation and Regulation
17.2 Exports and MRLs
17.3 EU certification
CHAPTER 18 ARGENTINA
18.1 Legislation and Regulation
18.2 Results
CHAPTER 19 MEXICO
19.1 Legislation and Regulation
19.2 MRLs
19.3 Results
19.4 EU relations
CHAPTER 20 BRAZIL
20.1 Legislation and Regulation
20.1.1 Banned substances
20.2 Results
20.2.1 Milk results
20.2.1.1 Antimicrobials
20.2.1.2 Avermectins
20.3 EU relations
CHAPTER 21 CANADA
21.1 Legislation and Regulation
CHAPTER 22 UNITED STATES
22.1 Legislation and Regulation
22.2 National residue monitoring
22.2.1 Domestic sampling
22.2.2 Testing results
22.2.2.1 Monitoring sampling results
22.2.2.2 Enforcement results
22.2.3 Import sampling
22.2.4 Non-compliance
CHAPTER 23 HORIZON ISSUES
23.1 Geographical and knowledge divide
23.1.1 Capacity building in developing countries
23.2 Technical considerations
23.2.1 Injection site residues
23.2.2 Residue depletion
23.2.3 Genotoxic and carcinogenic substances
23.2.4 Development of new techniques
REFERENCES
Ordering and More Information
Price and Delivery Options


MindBranch has been the leading provider of industry and investment research from more than 550 independent research firms since 1992. With over 90,000 market research reports, MindBranch is your trusted source of competitive business intelligence.